Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

Gideon M. Hirschfield, Olivier Chazouillères, Joost P. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles S. Landis, Marlyn J Mayo, Andrew J. Muir, James F. Trotter, Diana J. Leeming, Morten A. Karsdal, Mark J. Jaros, Lei Ling, Kathline H. Kim, Stephen J. Rossi, Ransi M. Somaratne, Alex M. DePaoli, Ulrich Beuers